Literature DB >> 371799

Combination chemotherapy with cyclophosphamide, vincristine, and prednisone in the treatment of refractory chronic lymphocytic leukemia.

M M Oken, M E Kaplan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 371799

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  8 in total

Review 1.  Management of chronic lymphocytic leukaemia.

Authors:  N Kalil; B D Cheson
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

2.  Repeated pentostatin (2'deoxycoformycin)-induced remissions in a patient with advanced chronic lymphocytic leukemia.

Authors:  R O Dillman; A L Yu; C N Qiao
Journal:  West J Med       Date:  1988-03

3.  Teniposide is not effective in chronic lymphocytic leukemia.

Authors:  V Zagonel; U Tirelli; A Veronesi; E Galligioni; S Tumolo; M Roncadin; A Carbone; E Grigoletto
Journal:  Blut       Date:  1986-01

Review 4.  Update on chronic lymphocytic leukemia: overview of new agents and comparative analysis.

Authors:  Sanford Kempin
Journal:  Curr Treat Options Oncol       Date:  2013-06

Review 5.  Chronic lymphocytic leukaemia: when and how to treat.

Authors:  C Rozman; E Montserrat
Journal:  Blut       Date:  1989-12

6.  Fludarabine phosphate for the treatment of low grade lymphoid malignancy.

Authors:  J S Whelan; C L Davis; S Rule; M Ranson; O P Smith; A B Mehta; D Catovsky; A Z Rohatiner; T A Lister
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

7.  An assessment of a short-term tumour chemosensitivity assay in chronic lymphocytic leukaemia.

Authors:  A G Bosanquet; M C Bird; W J Price; E D Gilby
Journal:  Br J Cancer       Date:  1983-06       Impact factor: 7.640

8.  Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL).

Authors:  Marco Montillo; Francesca Ricci; Sara Miqueleiz; Alessandra Tedeschi; Enrica Morra
Journal:  Biologics       Date:  2008-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.